Our division has a proud tradition of achievement in quality patient care, education of the next generation of Nephrologists, and research into the causes of, and treatments for, kidney disease. Our Division is large- over 41 faculty (33 MD, 8 PhD), with active clinical activity at 7 hospitals and over 700 dialysis patients. We are home to one of only 9 National Institutes of Health O’Brien centers for advanced imaging of kidneys to understand the mechanisms of disease. We are the only program to have back to back American Society of Nephrology Presidents, and are active leaders in the National Kidney Foundation and Renal Physicians Association.
U.S. News & World Report released its annual Best Hospitals rankings for 2016-2017, and IU Health's Nephrology specialty ranked 16th -- the only program ranked in the state. IU Health appeared on the prestigious list of the nation's top hospitals for the 18th year in a row. We are national leaders in home dialysis with one of the largest programs in the country and believe in empowering patients. We pride ourselves on high quality care with low mortality rates in our dialysis units. Our expertise in dialysis, hypertension, glomerulonephritis, pharmacogenomics, pharmacokinetics, anemia, mineral bone disorder, frailty, nutrition and polycystic kidney disease provide expertise for referrals from all over the Midwest and a training program that ensures our graduates are well equipped for the future.
Indiana University is home to the largest transplant program in the state, with over 200 kidneys transplanted annually. Our kidney and overall survival are above the national average, cared for by 5 transplant Nephrologists.
Our scientists and clinician-investigators perform a broad range of research from basic molecular and cellular biology to translational and clinical research. We are one of very few nephrology divisions with a large integrated clinical and basic research programs. Ongoing laboratory investigations are exploring the mechanisms and treatments of acute kidney injury, polycystic kidney disease, diabetic nephropathy, and understanding how tubular dysfunction leads to long term fibrosis and kidney failure. We are exploring complications of kidney disease including hypertension, vascular calcification, bone fractures, and muscle weakness. Ongoing translational research is investigating the role of three dimensional imaging of kidney biopsies and precision medicine defining genes that alter the course of disease or response to treatments. Our faculty have extramurally funded investigator initiated clinical trials in hypertension, polycystic kidney disease, frailty, nutrition, and phosphate homeostasis.
Please explore our website to learn more about our division and its many programs and feel free to contact us with any questions.
Sharon Moe, MD